Consensus Clinical Management Guideline for PLA2G6-Associated Neurodegeneration (PLAN).

Area of Science:

• Neurology
• Genetics
• Rare Diseases

Background:

• PLA2G6-associated neurodegeneration (PLAN) is a neurodegenerative disorder characterized by brain iron accumulation.
• PLAN presents with diverse clinical manifestations including infantile neuroaxonal dystrophy, juvenile, and adult-onset forms.
• Symptoms encompass motor, cognitive, ophthalmologic, and autonomic dysfunction.

Purpose of the Study:

• To establish a clinical guideline for the evaluation and management of individuals with PLAN.
• To provide evidence-based and expert-opinion recommendations for healthcare professionals.
• To address the diagnostic and therapeutic challenges associated with PLAN.

Main Methods:

• Development of the guideline utilized a modified Delphi process.
• Input was gathered from PLAN experts and affected family members.
• A literature search was conducted, with recommendations based on expert consensus in the absence of robust data.

Main Results:

• The guideline provides a structured diagnostic approach for PLAN.
• Recommendations cover disease-specific treatment strategies.
• Guidance is offered for the symptom-based management of PLAN manifestations.

Conclusions:

• This guideline offers a comprehensive framework for the clinical management of PLAN.
• It aims to improve patient care by standardizing diagnostic and therapeutic approaches.
• Further research is needed to generate more data for evidence-based recommendations.